Mercado VP, Acosta NV, Baltazar TJ?, Hernández OJL, Rivero SE, Domínguez CG

Language: Spanish
References: 21
Page: 47-53
PDF size: 286.25 Kb.

ABSTRACT

In March 2020, the World Health Organization (WHO) issued a pandemic alert for infection with coronavirus 2 of severe acute respiratory syndrome (SARS-CoV-2). This virus produces clinical symptoms that range from mild respiratory symptoms to pneumonia with severity criteria. The disease caused by the SARS-CoV-2 has been called coronavirus disease 19 (COVID-19). The SARS-CoV-2 has a high rate of contagion among humans, which means that the management of patients with COVID-19 implies a high risk of contagion for health personnel in the hospital setting. Therefore, it is important to have standardized management protocols that minimize the risk of contagion, especially during the performance of procedures that generate aerosols, which are considered the highest risk. Advanced airway management is included in this category of procedures. This document is not intended to replace current guidelines on the standardized control and management of infectious diseases. Its objective is to provide recommendations for the advanced management of the airway in this group of patients, which allow performing a procedure safely for the patient, promoting self-care of health personnel and preventing the spread of the virus in the hospital environment.

REFERENCES

1. World Health Organization. Novel Coronavirus (2019-nCoV). Data as reported by January 30, 2020. [accessed February 2020] Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2

2. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.

3. Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect. 2020;53(3):365-367. doi: 10.1016/j.jmii.2020.02.001.

4. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38(10):1420-1427.

5. Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia Outbreak: insights from publicly available data. PLoS Curr. 2014. doi: 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c.

6. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ. 2009;339:b5213.

7. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Addendum: a pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;588(7836):E6.

8. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207.

9. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970-971.

10. Buckley C. Chinese Doctor, silenced after warning of outbreak, dies from Coronavirus. The New York Times. [accessed February 2020] Available in: https://www.nytimes.com/2020/02/06/world/asia/chinese-doctor-Li-Wenliang-coronavirus.html

11. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team: The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19). China CDC Weekly. 2020;2:113-122.

12. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4):e35797.

13. Bowdle A, Munoz-Price LS. Preventing infection of patients and healthcare workers should be the new normal in the era of novel coronavirus epidemics. Anesthesiology. 2020;132(6):1292-1295. doi: 10.1097/ALN.0000000000003295.

14. Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier Enclosure during Endotracheal Intubation. N Engl J Med. 2020;382(20):1957-1958.

15. Chen X, Liu Y, Gong Y, Guo X, Zuo M, Li J, et al. Perioperative management of patients infected with the novel coronavirus: recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. Anesthesiology. 2020;132(6):1307-1316.

16. Fowler RA, Guest CB, Lapinsky SE, Sibbald WJ, Louie M, Tang P, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med. 2004;169(11):1198-1202.

17. Tung A, Fergusson NA, Ng N, Hu V, Dormuth C, Griesdale DEG. Medications to reduce emergence coughing after general anaesthesia with tracheal intubation: a systematic review and network meta-analysis. Br J Anaesth. 2020. doi: 10.1016/j.bja.2019.12.041.

18. Matava CT, Yu J, Denning S. Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19. Can J Anaesth. 2020;67(7):902-904.

19. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020;75(6):785-799.

20. Aziz MF, Dillman D, Fu R, Brambrink AM. Comparative effectiveness of the C-MAC video laryngoscope versus direct laryngoscopy in the setting of the predicted difficult airway. Anesthesiology. 2012;116(3):629-636.

21. Apfelbaum JL, Hagberg CA, Caplan RA, Blitt CD, Connis RT, Nickinovich DG, et al. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology. 2013;118(2):251-270.